Status: current, Defined. Date: 31-Aug 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5091135016 | Product containing precisely leuprorelin acetate 11.25 milligram/1 syringe powder for prolonged-release suspension for injection (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 5091136015 | Leuprorelin acetate 11.25 mg powder for prolonged-release suspension for injection syringe | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 5091137012 | Leuprolide acetate 11.25 mg powder for prolonged-release suspension for injection syringe | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Leuprorelin acetate 11.25 mg powder for prolonged-release suspension for injection syringe | Is a | Leuprorelin only product in parenteral dose form | true | Inferred relationship | Some | ||
| Leuprorelin acetate 11.25 mg powder for prolonged-release suspension for injection syringe | Has manufactured dose form | Powder for extended-release suspension for injection | true | Inferred relationship | Some | ||
| Leuprorelin acetate 11.25 mg powder for prolonged-release suspension for injection syringe | Has unit of presentation | Syringe | true | Inferred relationship | Some | ||
| Leuprorelin acetate 11.25 mg powder for prolonged-release suspension for injection syringe | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Leuprorelin acetate 11.25 mg powder for prolonged-release suspension for injection syringe | Has precise active ingredient | Leuprorelin acetate | true | Inferred relationship | Some | 1 | |
| Leuprorelin acetate 11.25 mg powder for prolonged-release suspension for injection syringe | Has BoSS | Leuprorelin acetate | true | Inferred relationship | Some | 1 | |
| Leuprorelin acetate 11.25 mg powder for prolonged-release suspension for injection syringe | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Leuprorelin acetate 11.25 mg powder for prolonged-release suspension for injection syringe | Has presentation strength denominator unit | Syringe | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian dialect reference set
FHIR